QTTBQ32 Bio Inc.Healthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $10.98 · now $10.98 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, QTTB has typically landed between $7.12 and $17.51 — a range of −35.2% to +59.4% from the issuance price $10.98.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

2,103 overlapping 1 month windows · 2018-03-282026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($10.98) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where QTTB has typically landed a month from the 2026-09-16 close of $10.98 — the range is history, not a prediction.

$7.12worst · -35.2%$17.51best · +59.4%
  • now $10.98 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $10.85 (-1.2%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $8.81$12.88
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $7.12$17.51
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,103 windows spanning 2018-03-28 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2024-11-12−91.5%−91.5%+0.0%
2024-11-13−91.2%−91.2%+0.0%
2024-11-11−90.6%−90.6%+0.0%
3 best
2026-05-04+177.8%+0.0%+177.8%
2024-06-25+159.6%+0.0%+159.6%
2026-05-05+155.1%+0.0%+172.4%

2,103 overlapping windows · 2018-03-282026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~9 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
63%
+2.0%
n=8
Feb
50%
+7.1%
n=8
Mar
25%
−6.2%
n=8
Apr
22%
−8.2%
n=9
May
56%
+11.2%
n=9
Jun
56%
+1.2%
n=9
Jul
56%
+22.4%
n=9
Aug
44%
−2.7%
n=9
Sep
56%
+0.2%
n=9
Oct
25%
−5.5%
n=8
Nov
38%
−11.3%
n=8
Dec
63%
−2.7%
n=8

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$18$22026-08-25: 3 insider sales, $275K — Morrison Jodie Pope, Kalowski Lee, Violette Shelia M.2026-05-28: 4 insider purchases, $30.0M — ORBIMED ADVISORS LLC, Xu Diyong …2026-02-25: 3 insider sales, $75K — Morrison Jodie Pope, Kalowski Lee, Violette Shelia M.2025-12-02: 2 insider sales, $109K — Morrison Jodie Pope, Kalowski Lee2025-08-26: 3 insider sales, $32K — Morrison Jodie Pope, Kalowski Lee, Violette Shelia M.2025-08: 3 open-market sales, $32K2025-12: 2 open-market sales, $109K2026-02: 3 open-market sales, $75K2026-05: 4 open-market purchases, $30.0M2026-08: 3 open-market sales, $275K↑ buys↓ salesdirector Morrison Jodie Pope — Sale on 2026-08-25, filed 2 days after the tradeofficer Kalowski Lee — Sale on 2026-08-25, filed 2 days after the tradeofficer Violette Shelia M. — Sale on 2026-08-25, filed 2 days after the tradedirector ORBIMED ADVISORS LLC — Purchase on 2026-05-28, filed 4 days after the tradedirector Xu Diyong — Purchase on 2026-05-28, filed 4 days after the tradedirector Xu Diyong — Purchase on 2026-05-28, filed 4 days after the tradedirector ORBIMED ADVISORS LLC — Purchase on 2026-05-28, filed 4 days after the tradedirector Morrison Jodie Pope — Sale on 2026-02-25, filed 2 days after the tradeofficer Kalowski Lee — Sale on 2026-02-25, filed 2 days after the tradeofficer Violette Shelia M. — Sale on 2026-02-25, filed 2 days after the tradedirector Morrison Jodie Pope — Sale on 2025-12-02, filed 2 days after the tradeofficer Kalowski Lee — Sale on 2025-12-02, filed 2 days after the tradedirector Morrison Jodie Pope — Sale on 2025-08-26, filed 2 days after the tradeofficer Kalowski Lee — Sale on 2025-08-26, filed 2 days after the tradeofficer Violette Shelia M. — Sale on 2025-08-26, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-25Morrison Jodie PopedirectorSale9,845 @ $16.56$163K−2.8% of holdingnot yet — horizon still opennot yet — horizon still open343,259Form 4 · filed 2 days after the trade
2026-08-25Kalowski LeeofficerSale3,972 @ $16.56$66K−2.8% of holdingnot yet — horizon still opennot yet — horizon still open138,471Form 4 · filed 2 days after the trade
2026-08-25Violette Shelia M.officerSale2,798 @ $16.56$46K−2.1% of holdingnot yet — horizon still opennot yet — horizon still open127,771Form 4 · filed 2 days after the trade
2026-05-28ORBIMED ADVISORS LLCdirectorPurchase1,250,000 @ $8.00$10.0M+55.5% of holding+38.7%not yet — horizon still open3,502,987Form 4 · filed 4 days after the trade
2026-05-28Xu DiyongdirectorPurchase1,250,000 @ $8.00$10.0M+55.5% of holding+38.7%not yet — horizon still open3,502,987Form 4 · filed 4 days after the trade
2026-05-28Xu DiyongdirectorPurchase625,000 @ $8.00$5.0Mownership Δ n/a+38.7%not yet — horizon still open625,000Form 4 · filed 4 days after the trade
2026-05-28ORBIMED ADVISORS LLCdirectorPurchase625,000 @ $8.00$5.0Mownership Δ n/a+38.7%not yet — horizon still open625,000Form 4 · filed 4 days after the trade
2026-02-25Morrison Jodie PopedirectorSale9,896 @ $4.51$45K−10.0% of holding+57.6%+206.2%89,104Form 4 · filed 2 days after the trade
2026-02-25Kalowski LeeofficerSale3,995 @ $4.51$18K−10.0% of holding+57.6%+206.2%35,943Form 4 · filed 2 days after the trade
2026-02-25Violette Shelia M.officerSale2,815 @ $4.51$13K−4.8% of holding+57.6%+206.2%55,569Form 4 · filed 2 days after the trade
2025-12-02Morrison Jodie PopedirectorSale22,506 @ $3.46$78K−18.5% of holding+0.3%+275.6%99,000Form 4 · filed 2 days after the trade
2025-12-02Kalowski LeeofficerSale9,072 @ $3.46$31K−18.5% of holding+0.3%+275.6%39,938Form 4 · filed 2 days after the trade
2025-08-26Morrison Jodie PopedirectorSale10,494 @ $1.80$19K−8.0% of holding+1.0%+143.6%121,506Form 4 · filed 2 days after the trade
2025-08-26Kalowski LeeofficerSale4,240 @ $1.80$8K−8.0% of holding+1.0%+143.6%49,010Form 4 · filed 2 days after the trade
2025-08-26Violette Shelia M.officerSale2,990 @ $1.80$5K−4.9% of holding+1.0%+143.6%58,384Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

100 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-07-16Morrison Jodie PopedirectorAward / grant132,000353,104Form 4
2026-07-16Violette Shelia M.officerAward / grant37,500130,569Form 4
2026-07-16Kalowski LeeofficerAward / grant53,250142,443Form 4
2026-06-30Manke IsaacdirectorOption exercise53,52153,521Form 4
2026-06-30Manke IsaacdirectorOption exercise53,5210Form 4
2026-06-12Manke IsaacdirectorAward / grant9,8109,810Form 4
2026-06-12Xu DiyongdirectorAward / grant9,8109,810Form 4
2026-06-12Thistle MarydirectorAward / grant9,8109,810Form 4
2026-06-12TZIANABOS ARTHURdirectorAward / grant9,8109,810Form 4
2026-06-12LAPORTE KATHLEENdirectorAward / grant9,8109,810Form 4
2026-06-12Lundberg Sven AntedirectorAward / grant9,8109,810Form 4
2026-06-12GRAYZEL DAVID S.directorAward / grant9,8109,810Form 4
2026-06-12Iwicki Mark TdirectorAward / grant9,8109,810Form 4
2026-02-24Morrison Jodie PopedirectorAward / grant132,000221,104Form 4
2026-02-24Violette Shelia M.officerAward / grant37,50093,069Form 4
2026-02-24Kalowski LeeofficerAward / grant53,25089,193Form 4
2026-01-15LAPORTE KATHLEENdirectorAward / grant23,27223,272Form 4
2026-01-15Lundberg Sven AntedirectorAward / grant20,36320,363Form 4
2026-01-15GRAYZEL DAVID S.directorAward / grant16,36316,363Form 4
2025-10-23Iwicki Mark TdirectorAward / grant53,52153,521Form 4
2025-10-23LAPORTE KATHLEENdirectorAward / grant53,52153,521Form 4
2025-10-23TZIANABOS ARTHURdirectorAward / grant53,52153,521Form 4
2025-10-23Thistle MarydirectorAward / grant53,52153,521Form 4
2025-10-23Lundberg Sven AntedirectorAward / grant53,52153,521Form 4
2025-10-23Manke IsaacdirectorAward / grant53,52153,521Form 4
2025-10-23Xu DiyongdirectorAward / grant53,52153,521Form 4
2025-02-24TZIANABOS ARTHURdirectorAward / grant12,76712,767Form 4
2025-02-24Campagna JasonofficerAward / grant37,50037,500Form 4
2025-02-24Campagna JasonofficerAward / grant87,73887,738Form 4
2025-02-24Campagna JasonofficerDisposition17,9510Form 4
2025-02-24Campagna JasonofficerDisposition87,7380Form 4
2025-02-24Campagna JasonofficerAward / grant17,95117,951Form 4
2025-02-24Campagna JasonofficerDisposition70,6870Form 4
2025-02-24Campagna JasonofficerAward / grant70,68770,687Form 4
2025-02-24GRAYZEL DAVID S.directorDisposition12,7670Form 4
2025-02-24GRAYZEL DAVID S.directorAward / grant12,76712,767Form 4
2025-02-24GRAYZEL DAVID S.directorDisposition2,5690Form 4
2025-02-24GRAYZEL DAVID S.directorAward / grant2,5692,569Form 4
2025-02-24GRAYZEL DAVID S.directorDisposition18,5950Form 4
2025-02-24GRAYZEL DAVID S.directorAward / grant18,59518,595Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.